Related Experiment Video

Updated: May 12, 2026

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

Issues in pediatric haemophilia care

Paola Giordano1, Massimo Franchini, Giuseppe Lassandro

  • 1Dipartimento di Scienze Biomediche ed Oncologia Umana, Clinica Pediatrica, Università degli Studi di Bari Aldo Moro, Bari, Italy. paola.giordano@uniba.it

Italian Journal of Pediatrics
|April 23, 2013
PubMed

Insights

Hemophilias, X-linked bleeding disorders, require specialized care in children. Prophylaxis and comprehensive strategies improve quality of life and prevent lifelong disabilities.

Area of Science:

  • Hematology
  • Genetics
  • Pediatrics

Background:

  • Hemophilias are common X-linked inherited bleeding disorders.
  • Pediatric challenges differ from adult cases, risking chronic disease and disability if unmanaged.
  • Inhibitor development is a severe complication, necessitating advanced treatment strategies.

Purpose of the Study:

  • To highlight the distinct challenges in managing hemophilia in children.
  • To emphasize the importance of prophylaxis as an optimal preventive care strategy.
  • To underscore the shift towards prioritizing quality of life in hemophilia patient care.

Main Methods:

  • Review of current hemophilia management protocols.
  • Analysis of pediatric vs. adult hemophilia care challenges.
  • Evaluation of emerging preventive strategies like prophylaxis.
  • Assessment of quality of life as a primary care objective.

Main Results:

  • Prophylaxis is emerging as the optimal preventive strategy for hemophilia.
  • Comprehensive care, including psychotherapy and physiotherapy, is crucial.
  • Addressing patient and family perception of health is key to improving quality of life.

Conclusions:

  • Effective hemophilia management in children requires a multifaceted approach beyond factor replacement.
  • Prophylaxis and integrated care strategies are vital for preventing long-term complications.
  • Enhancing quality of life is the central goal in modern hemophilia care, encompassing physical, psychological, and social well-being.

More Related Videos

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock09:09

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

Published on: November 3, 2023

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...